The value of lymphocyte C-reactive protein ratio in the prediction of postoperative delirium in elderly patients undergoing gastrointestinal malignant tumors

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078422

Enrollment

Unknown

Registered

2023-12-07

Start date

2023-12-10

Completion date

Unknown

Last updated

2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

POD group:none

Non-POD group:none

Eligibility

Sex/Gender

All

Age

60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Primary tumor, gastric or colorectal cancer confirmed by histopathology; 2.Radical gastrectomy for gastric cancer or radical resection for colorectal cancer; 3. without preoperative chemoradiotherapy; 4.Age above 60 years old and below 90 years old; 5.American Society of Anesthesiologists (ASA) grade II-III. 6. no infectious diseases affecting lymphocytes and Alb; 7. No immune diseases

Exclusion criteria

Exclusion criteria: 1: Patients with language impairment dementia coma deafness blindness and other symptoms who were unable to cooperate with the study; 2: comorbid psychotic o neurological diseases; 3: Severe liver and kidney dysfunction; 4: blood diseases; 5: death or loss of follow-up within 7 days after operation.

Design outcomes

Primary

Measure	Time frame
LCR;The incidence of POD;	—

Countries

China

Contacts

Public ContactLi Jianli

Hebei General Hospital

hblijianli@163.com+86 137 8511 8676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026